Your browser doesn't support javascript.
loading
Essential medicines list in national cancer control plans: a secondary analysis from a global study.
Razis, Evangelia; Kassapian, Marie; Andriakopoulou, Charitini; Martei, Yehoda M; Zurn, Shalini Jayasekar; Hammad, Nazik; Romero, Yannick; Dafni, Urania; Ilbawi, André M; Trapani, Dario.
  • Razis E; 3rd Department of Medical Oncology, Hygeia Hospital, Athens, Greece. Electronic address: evangelia@razis.net.
  • Kassapian M; Frontier Science Foundation Hellas, Athens, Greece.
  • Andriakopoulou C; Frontier Science Foundation Hellas, Athens, Greece.
  • Martei YM; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA, USA.
  • Zurn SJ; Knowledge, Advocacy and Policy, Union for International Cancer Control, Geneva, Switzerland.
  • Hammad N; Kingston Health Sciences Centre Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, ON, USA.
  • Romero Y; Knowledge, Advocacy and Policy, Union for International Cancer Control, Geneva, Switzerland.
  • Dafni U; Frontier Science Foundation Hellas, Athens, Greece; School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
  • Ilbawi AM; Department of Non-communicable Diseases, World Health Organization, Geneva, Switzerland.
  • Trapani D; European Institute of Oncology, IRCCS, Milan, Italy.
Lancet Oncol ; 23(3): e144-154, 2022 03.
Article en En | MEDLINE | ID: mdl-35240089
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Medicamentos Esenciales / Neoplasias Tipo de estudio: Guideline / Health_economic_evaluation Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Medicamentos Esenciales / Neoplasias Tipo de estudio: Guideline / Health_economic_evaluation Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article